Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16,284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
LCAT- targeted therapies: Progress, failures and future.
Yang K, Wang J, Xiang H, Ding P, Wu T, Ji G. Yang K, et al. Biomed Pharmacother. 2022 Mar;147:112677. doi: 10.1016/j.biopha.2022.112677. Epub 2022 Feb 2. Biomed Pharmacother. 2022. PMID: 35121343 Free article. Review.
Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomas.
Demirkiran C, Greenman M, Bellone S, McNamara B, Hartwich TMP, Manavella D, Mutlu L, Zipponi M, Yang-Hartwich Y, Yang K, Ratner E, Schwartz PE, Coma S, Pachter J, Santin AD. Demirkiran C, et al. Among authors: yang k. Gynecol Oncol. 2024 May 3;187:12-20. doi: 10.1016/j.ygyno.2024.04.010. Online ahead of print. Gynecol Oncol. 2024. PMID: 38703673
The Chinese keratoconus (CKC) cohort study.
Yang K, Liu X, Xu L, Gu Y, Fan Q, Yin S, Wang Y, Yuan Y, Chang A, Zang Y, Yin C, Pang C, Wang C, Ren S. Yang K, et al. Eur J Epidemiol. 2024 May 4. doi: 10.1007/s10654-024-01128-2. Online ahead of print. Eur J Epidemiol. 2024. PMID: 38703249
Acinar to β-like cell conversion through inhibition of focal adhesion kinase.
Dahiya S, Saleh M, Rodriguez UA, Rajasundaram D, R Arbujas J, Hajihassani A, Yang K, Sehrawat A, Kalsi R, Yoshida S, Prasadan K, Lickert H, Hu J, Piganelli JD, Gittes GK, Esni F. Dahiya S, et al. Among authors: yang k. Nat Commun. 2024 May 3;15(1):3740. doi: 10.1038/s41467-024-47972-4. Nat Commun. 2024. PMID: 38702347
Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Shadman M, Tedeschi A, Mohseninejad L, Yang K, Lamanna N, Xu S, Cohen A, Challagulla S, Xue M, Williams R, O'Brien SM, Brown JR, Tam C. Shadman M, et al. Among authors: yang k. Blood Cancer J. 2024 May 2;14(1):77. doi: 10.1038/s41408-024-01044-4. Blood Cancer J. 2024. PMID: 38697986 No abstract available.
16,284 results
You have reached the last available page of results. Please see the User Guide for more information.